» Articles » PMID: 25118238

Differential Modulation by Akkermansia Muciniphila and Faecalibacterium Prausnitzii of Host Peripheral Lipid Metabolism and Histone Acetylation in Mouse Gut Organoids

Overview
Journal mBio
Specialty Microbiology
Date 2014 Aug 14
PMID 25118238
Citations 222
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The gut microbiota is essential for numerous aspects of human health. However, the underlying mechanisms of many host-microbiota interactions remain unclear. The aim of this study was to characterize effects of the microbiota on host epithelium using a novel ex vivo model based on mouse ileal organoids. We have explored the transcriptional response of organoids upon exposure to short-chain fatty acids (SCFAs) and products generated by two abundant microbiota constituents, Akkermansia muciniphila and Faecalibacterium prausnitzii. We observed that A. muciniphila metabolites affect various transcription factors and genes involved in cellular lipid metabolism and growth, supporting previous in vivo findings. Contrastingly, F. prausnitzii products exerted only weak effects on host transcription. Additionally, A. muciniphila and its metabolite propionate modulated expression of Fiaf, Gpr43, histone deacetylases (HDACs), and peroxisome proliferator-activated receptor gamma (Pparγ), important regulators of transcription factor regulation, cell cycle control, lipolysis, and satiety. This work illustrates that specific bacteria and their metabolites differentially modulate epithelial transcription in mouse organoids. We demonstrate that intestinal organoids provide a novel and powerful ex vivo model for host-microbiome interaction studies.

Importance: We investigated the influence of the gut microbiota and microbially produced short-chain fatty acids (SCFAs) on gut functioning. Many commensal bacteria in the gut produce SCFAs, particularly butyrate, acetate, and propionate, which have been demonstrated to reduce the risk of gastrointestinal disorders. Organoids-small crypt-villus structures grown from ileal intestinal stem cells-were exposed to SCFAs and two specific gut bacteria. Akkermansia muciniphila, found in the intestinal mucus, was recently shown to have a favorable effect on the disrupted metabolism associated with obesity. Faecalibacterium prausnitzii is a commensal gut bacterium, the absence of which may be associated with Crohn's disease. We showed that in our model, A. muciniphila induces stronger effects on the host than F. prausnitzii. We observed that A. muciniphila and propionate affect the expression of genes involved in host lipid metabolism and epigenetic activation or silencing of gene expression. We demonstrated that organoids provide a powerful tool for host-microbe interaction studies.

Citing Articles

Cardiac energy metabolic disorder and gut microbiota imbalance: a study on the therapeutic potential of Shenfu Injection in rats with heart failure.

Zhao Z, Hu Z, Li L Front Microbiol. 2025; 16:1509548.

PMID: 40071211 PMC: 11895768. DOI: 10.3389/fmicb.2025.1509548.


Big lessons from the little in hepatocellular carcinoma.

Yang Y, Shi X Front Immunol. 2025; 16:1524563.

PMID: 40028328 PMC: 11868108. DOI: 10.3389/fimmu.2025.1524563.


Effects of SWM 008-Fermented Red Mold Rice and Its Functional Components on Gut Microbiota and Metabolic Health in Rats.

Yang P, You C, Lin Y, Wang C, Hsu Y, Pan T Foods. 2025; 14(4).

PMID: 40002095 PMC: 11854857. DOI: 10.3390/foods14040651.


The Use of Gut Organoids: To Study the Physiology and Disease of the Gut Microbiota.

Deng Y, Yuan X, Lu X, Wu J, Luo C, Zhang T J Cell Mol Med. 2025; 29(4):e70330.

PMID: 39968926 PMC: 11836903. DOI: 10.1111/jcmm.70330.


The role of in maintaining health: a bibliometric study.

Gao F, Cheng C, Li R, Chen Z, Tang K, Du G Front Med (Lausanne). 2025; 12:1484656.

PMID: 39967592 PMC: 11833336. DOI: 10.3389/fmed.2025.1484656.


References
1.
Colin S, Bourguignon E, Boullay A, Tousaint J, Huet S, Caira F . Intestine-specific regulation of PPARalpha gene transcription by liver X receptors. Endocrinology. 2008; 149(10):5128-35. DOI: 10.1210/en.2008-0637. View

2.
Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N . Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. DOI: 10.2337/db07-1403. View

3.
Neef A, Sanz Y . Future for probiotic science in functional food and dietary supplement development. Curr Opin Clin Nutr Metab Care. 2013; 16(6):679-87. DOI: 10.1097/MCO.0b013e328365c258. View

4.
Roeselers G, Ponomarenko M, Lukovac S, Wortelboer H . Ex vivo systems to study host-microbiota interactions in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2013; 27(1):101-13. DOI: 10.1016/j.bpg.2013.03.018. View

5.
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran L, Gratadoux J . Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105(43):16731-6. PMC: 2575488. DOI: 10.1073/pnas.0804812105. View